A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines

Area of Science:

• Immunology
• Pharmacology
• Vaccinology

Background:

• The COVID-19 pandemic accelerated mRNA vaccine technology development.
• Mathematical modeling is crucial for expediting vaccine research and development.

Purpose of the Study:

• To introduce a Quantitative Systems Pharmacology (QSP) model for mRNA vaccines.
• To mechanistically link molecular events to immune responses post-vaccination.

Main Methods:

• Developed a two-layer QSP model detailing biological processes from mRNA uptake to antibody release.
• Calibrated and validated the model for BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccines.
• Simulated various dosing regimens and administration schedules.

Main Results:

• The model effectively captures key immune responses following mRNA vaccine administration.
• Demonstrated optimization of dosing strategies and identified differences in immune responses, especially in elderly populations.
• Validated model adaptability for different mRNA vaccines.

Conclusions:

• The QSP model provides a robust framework for mRNA vaccine development and optimization.
• Highlights the potential for integrating vaccine-specific attributes into modeling.
• Emphasizes the model's versatility for broader mRNA vaccine research.